Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Update on the recent development of allosteric modulators for adenosine receptors and their therapeutic applications
Silvia Pasquini, Chiara Contri, Martina Cappello, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 15

Showing 15 citing articles:

Retrospective Clinical Investigation into the Association Between Abnormal Blood Clotting, Oral Anticoagulant Therapy, and Medium-Term Mortality in a Cohort of COVID-19 Patients
Giorgia Dinoi, Maria Vittoria Togo, Pietro Guida, et al.
Biomedicines (2025) Vol. 13, Iss. 3, pp. 535-535
Open Access | Times Cited: 1
A unified hypothesis of SUDEP: Seizure‐induced respiratory depression induced by adenosine may lead to SUDEP but can be prevented by autoresuscitation and other restorative respiratory response mechanisms mediated by the action of serotonin on the periaqueductal gray
Carl L. Faingold, Huajun Feng
Epilepsia (2023) Vol. 64, Iss. 4, pp. 779-796
Closed Access | Times Cited: 22
New paradigms in purinergic receptor ligand discovery
Kenneth A. Jacobson, Balaram Pradhan, Zhiwei Wen, et al.
Neuropharmacology (2023) Vol. 230, pp. 109503-109503
Open Access | Times Cited: 17
Pharmacology of Adenosine Receptors: Recent Advancements
Fabrizio Vincenzi, Silvia Pasquini, Chiara Contri, et al.
Biomolecules (2023) Vol. 13, Iss. 9, pp. 1387-1387
Open Access | Times Cited: 17
Drug Development for Alzheimer’s and Parkinson’s Disease: Where Do We Go Now?
Lisa Sequeira, Sofia Benfeito, Carlos Fernandes, et al.
Pharmaceutics (2024) Vol. 16, Iss. 6, pp. 708-708
Open Access | Times Cited: 6
The Emerging Landscape of Natural Small-molecule Therapeutics for Huntington’s Disease
Shahnawaz Ali Bhat, Shakir Ahamad, Nawab John Dar, et al.
Current Neuropharmacology (2023) Vol. 21, Iss. 4, pp. 867-889
Open Access | Times Cited: 14
Adenosine A3 Receptor: From Molecular Signaling to Therapeutic Strategies for Heart Diseases
Ratchanee Duangrat, Warisara Parichatikanond, Wisinee Chanmahasathien, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 5763-5763
Open Access | Times Cited: 5
The Effects of Caffeine on Blood Platelets and the Cardiovascular System through Adenosine Receptors
Kinga Marcinek, Bogusława Luzak, M. Różalski
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 16, pp. 8905-8905
Open Access | Times Cited: 1
Adenosine A2A signaling in mood disorders: how far have we come?
Laura Menegatti Bevilacqua, Francisco da Silveira Neto, Manuella P. Kaster
IBRO Neuroscience Reports (2024)
Open Access | Times Cited: 1
Investigation of adenosine A1 receptor-mediated β-arrestin 2 recruitment using a split-luciferase assay
Luisa Saecker, Hanns Häberlein, Sebastian Franken
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 3
Namodenoson Inhibits the Growth of Pancreatic Carcinoma via Deregulation of the Wnt/β-catenin, NF-κB, and RAS Signaling Pathways
Inbal Itzhak, Avital Bareket‐Samish, Pnina Fishman
Biomolecules (2023) Vol. 13, Iss. 11, pp. 1584-1584
Open Access | Times Cited: 2
Hyperbaric oxygen attenuates chronic postsurgical pain by regulating the CD73/adenosine/A1R axis of the spinal cord in rats
Lijun Yin, Wenwu Liu, Zhe Zhang, et al.
Journal of Pain (2024) Vol. 25, Iss. 11, pp. 104623-104623
Closed Access
Problems and prospects for finding new pharmacological agents among adenosine receptor agonists, antagonists, or their allosteric modulators for the treatment of cardiovascular diseases
В. Н. Перфилова, Е. А. Музыко, A. S. Taran, et al.
Biomeditsinskaya Khimiya (2023) Vol. 69, Iss. 6, pp. 353-370
Open Access | Times Cited: 1
Investigation of adenosine A1 receptor mediated β-arrestin 2 recruitment using a split-luciferase assay
Luisa Saecker, Hanns Häberlein, Sebastian Franken
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Pyrazolo-triazolo-pyrimidine Scaffold as a Molecular Passepartout for the Pan-Recognition of Human Adenosine Receptors
Veronica Salmaso, Margherita Persico, Tatiana Da Ros, et al.
Biomolecules (2023) Vol. 13, Iss. 11, pp. 1610-1610
Open Access
Page 1

Scroll to top